Tenet Healthcare Raises Adjusted EBITDA Outlook for 2026
Tenet Healthcare (NYSE: THC) has raised its adjusted EBITDA outlook for 2026 to a range of $4.83 billion to $5.03 billion, reflecting strong hospital volumes and same-store revenue growth. The company also announced an expansion of its share repurchase authorization by $2 billion, signaling confidence in its financial performance. Chairman & CEO Saumya Sutaria highlighted the business's fundamental strength during a recent earnings call, noting that results have consistently exceeded internal goals. This update suggests continued momentum for Tenet as it navigates post-pandemic healthcare demand and operational efficiency improvements.
Tickers: $THC